Impact of first-line (1L) therapy on outcomes of adult patients (pts) with metastatic MiT family translocation renal cell carcinomas (TRCC) treated in the contemporary immune checkpoint therapy (ICT) era Meeting Abstract
| Authors: | Thouvenin, J.; Alhalabi, O.; Carlo, M.; Ajuria, L. C.; Bakouny, Z.; Chanza, N. M.; Negrier, S.; Campedel, L.; Bilen, M. A.; Borchiellini, D.; Chahoud, J.; Vano, Y. A.; Lodi, M.; Barthelemy, P.; Viswanathan, S. R.; Msaouel, P.; Choueiri, T. K.; Albiges, L.; Tannir, N.; Malouf, G. |
| Abstract Title: | Impact of first-line (1L) therapy on outcomes of adult patients (pts) with metastatic MiT family translocation renal cell carcinomas (TRCC) treated in the contemporary immune checkpoint therapy (ICT) era |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1213 |
| End Page: | S1214 |
| Language: | English |
| ACCESSION: | WOS:000866211602015 |
| DOI: | 10.1016/j.annonc.2022.07.1564 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1461P -- Source: Wos |
